author-photo

Xiaorui Wang

Tianjin Medical University Cancer Institute and Hospital

4

Papers

0

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer.

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Ribosome Proteins Represented by RPL27A Mark the Development and Metastasis of Triple-Negative Breast Cancer in Mouse and Human.

2021 Frontiers in Cell and Developmental Biology
Show All
- Source
- Cite
- Save
Citations (0)
Paclitaxel plus carboplatin versus paclitaxel plus epirubicin as first-line treatment for metastatic breast cancer: Efficacy and safety results of a randomized, phase III trial.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P3-10-05: Phase III trial evaluating paclitaxel plus carboplatin versus paclitaxel plus epirubicin as first-line treatment for metastatic breast cancer

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)